matteo monami - Società Italiana di Diabetologia

Curriculum Vitae30/01/2014
Matteo Monami
Curriculum Vitae
MATTEO MONAMI
INFORMAZIONI PERSONALI
Nome e Cognome
Data di nascita
Luogo di nascita
Sesso
Nazionalità
Matteo Monami
25 marzo 1974
Firenze
Maschile
Italiana
Recapiti personali:
Indirizzo
Telefono
E-mail
Via Domenico Maria Manni n. 2 – 50135 Firenze
055.604375 – 338 4027484
[email protected]
Recapiti lavorativi:
Indirizzo
Telefono
Fax
E-mail
DH Diabetologico, Ponte Nuovo pad. 28,
Cardiologia Geriatrica
Azienda Ospedaliero-Universitaria Careggi
Via delle Oblate, 4 – 50141 Firenze
055.7946563–055.7949332
055.7949660
[email protected]
POSIZIONE ATTUALE Dirigente Medico I Livello, Disciplina Geriatria
Responsabile Servizio Medicazioni Piede Diabetico
Azienda Ospedaliero-Universitaria Careggi, Firenze
ESPERIENZA
PROFESSIONALE
Dal 01/2012
Responsabile Servizio Medicazioni Piede Diabetico
Azienda Ospedaliero-Universitaria Careggi, Firenze
Dal 10/2008
ad oggi
Dirigente Medico I livello, disciplina Geriatria, tempo indeterminato
Dal 01/2004
al 09/2008
Assegnista di ricerca
Dal 2005
al 2007
Cardiologia e Medicina Geriatrica
Azienda Ospedaliero-Universitaria Careggi, Firenze
Unità di Geriatria
Università degli Studi di Firenze
Dottorato di ricerca
Unità di Geriatria
Università degli Studi di Firenze
1/13
Curriculum Vitae30/01/2014
Matteo Monami
TITOLI DI STUDIO
25.05.2007
Dottorato di ricerca
Fisiopatologia clinica dell’invecchiamento
Università degli Studi di Firenze
Tesi: “Prevenzione, prognosi e trattamento delle lesioni ulcerative in pazienti anziani
diabetici di tipo 2”
Relatore Prof. Giulio Masotti
23.10.2003
Specializzazione in Geriatria
Università degli Studi di Firenze
Voto: 70/70 cum laude
Tesi: “Risposta emodinamica e distrettuale renale alla dopamina in pazienti anziani con
scompenso cardiaco congestizio”
Relatore Prof. Niccolò Marchionni
14.10.1999
Laurea in Medicina e Chirurgia
Università degli Studi di Firenze
Voto: 110/110 cum laude
10.07.1993
Maturità Scientifica
Liceo Scientifico P. Gobetti, Firenze
Voto: 56/60
ATTIVITA’
DIDATTICA
2014 – oggi
Scuola Specializzazione in Geriatria
Docente
Università degli Studi di Firenze
2004-2005
Docente a Master di I livello in Infermieristica
Docente
Università degli Studi di Firenze
2004 – oggi
Corso di Laurea per Fisioterapisti
Docente
Università degli Studi di Firenze
ATTIVITA’
EDITORIALI
Membro di Board
Editoriali
Attualmente membro del board editoriale delle seguenti riviste:
Internazionali
•
Experimental Diabetes Research (2011-2012)
•
International Journal of Endocrinology (2013)
Nazionali
•
Il Diabete (dal 2013)
•
Componente del Comitato Editoriale SID per il biennio 2014 – 2016.
Attività di revisore
Aging Clinical and Experimental Research, Acta Diabetologica, Advances in Therapy,
American Heart Journal, Annals of Internal Medicine, Archives of Medical Research, BMC
Endocrine Disorders, Diabetes Care, Diabetes Metabolism Research and Reviews,
Diabetes Nutrition and Metabolism, Diabetes Researchand Clinical Practice, Diabetic
Medicine, Diabetologia, Drugs Aging,, International Journal of Endocrinology , Journal of
Diabetes and its complications, Journal ofEndocrinological Investigation, Journal of Internal
Medicine, Journal of Sexual Medicine, Nature Reviews Endocrinology, Nutrition Metabolism
and Cardiovascular Disease, PLoS ONE.
SOCIETA’
2/13
Curriculum Vitae30/01/2014
Matteo Monami
SCIENTIFICHE
Società Italiana di
Diabetologia
(SID)
•
•
•
Membro del Comitato Editoriale (2014 ad oggi)
Membro del Direttivo Sezione Regionale Toscana (2011 ad oggi)
Socio Ordinario (dal 2003)
Società Italiana
dell’Obesità
(SIO)
•
Socio Ordinario (dal 2005-2010)
Società Italiana
Geriatria e
Gerontologia (SIGG)
•
Socio Ordinario (dal 1999)
Società Italiana di
Ipertensione Arteriosa
(SIIA)
•
Socio Ordinario (2000-2002)
ALTRE
INFORMAZIONI
Lingua madre
Altre lingue
Competenze
informatiche
Competenze
comunicative
Competenze
professionali
Italiano
Inglese, livello avanzato
Buona padronanza di:
•
Microsoft Office
•
SPSS
•
Comprehensive Meta-Analysis
•
•
Ampia esperienza didattica (vedi sopra)
Relatore a numerosi Congressi Nazionali e Internazionali
Esperienza nel disegno di studi clinici, ed in particolare:
▪
Trial clinici randomizzati;
▪
Studi epidemiologici trasversali e longitudinali;
▪
Meta-analisi di trial e studi osservazionali;
▪
Creazione e validazione di test psicometrici originali
Ha ampia esperienza nell’esecuzione di trial clinici in GoodClinicalPractice; è coordinatore
nazionalein due studi multicentrici multinazionali.
Nel corso degli anni, ha svolto attività di ricerca nei settori del diabete e malattie
cardiovascolari e in particolare:
▪ Messa a punto e verifica di programmi educativi per il diabete
▪ Valutazioni epidemiologiche sulle comorbilità nel diabete mellito
▪ Valutazione di strategie per lo screening del diabete nella popolazione a rischio
▪ Valutazione dell’efficacia e tollerabilità dei trattamenti per il diabete, attrraverso trial clinici,
studi osservazionali e meta-analisi di trial e di studi epidemiologici.
-Valutazioni epidemiologiche su malattie geriatriche e cardiovascolari
PREMI E RICONOSCIMENTI
Congresso SID-AMD
2005 (Prato)
Premio come migliore comunicazione scientifica, con la relazione dal titolo: MORTALITA’
PER TUTTE LE CAUSE IN UNA POPOLAZIONE DI DIABETICI DI TIPO 2 TRATTATI CON
ASSOCIAZIONI DI SULFANILUREE–BIGUANIDI.
3/13
Curriculum Vitae30/01/2014
Matteo Monami
PUBBLICAZIONI
Numero pubblicazioni
Primo autore
Secondo autore
Ultimo autore
Totale
45
4
3
52
22
4
5
31
0
0
0
0
108
9
8
125
Primo autore
Secondo autore
Ultimo autore
Totale
172.365
3.786
19.448
195.599
82.362
5.433
70.107
157.902
0
0
0
0
368.046
11.112
89.555
468.713
Articoli originali
Revisioni/editoriali
Lettere (originali)
Totale
Impact Factor(base 2012)
Articoli originali
Revisioni/editoriali
Lettere (originali)
Totale
Indici bibliometrici(fonte: Google Scholar)
Google Scholar
h-index
i10-index
Numero citazioni
Totale
33
68
3141
Dal 2009
32
65
2879
4/13
Curriculum Vitae30/01/2014
Matteo Monami
ELENCO DELLE PUBBLICAZIONI
LIST OF PUBLICATIONS
RIVISTE INTERNAZIONALI CON COMITATO EDITORIALE
INTERNATIONAL PEER-REVIEWED JOURNALS
Articoli originali*
OriginalArticles
2002
1.
2.
3.
2004
1.
2.
3.
4.
2005
1.
2.
2006
1.
2.
3.
4.
5.
6.
7.
2007
1.
Petruzzi E., Pinzani P., Poggesi M., Monami M., Masotti G. Serum Total Antioxidant Capacity (TAC),
Dehydroepiandrosteronesulphate (DHEAS) and Insulin-like Growth Factor-1 (IGF-1) in Healthy
Centenarian subjects, J Endocrinol Invest 25: 83-84. IF: 1.525
Petruzzi E., Pinzani P., Orlando C., Poggesi M., Monami M., Pazzagli M., Masotti G. Healthy
centenarian subjects as living model of "successful aging": A study on fasting glycemia, C-peptide,
dehydroepiandrosteronesulphate (DHEAS) and insulin-like growth factor (IGF-1). Arch
GerontolGeriatrSuppl8:273-278. IF: 1.289
Petruzzi E., Pinzani P., Poggesi M., Monami M., Masotti G. Age-related changes in serum total
antioxidant capacity (TAC), dehydroepiandrosteronesulphate (DHEAS), and insulin-like growth
factor-1 (IGF-1): evidence in healthy centenarian subjects. Arch GerontolGeriatrSuppl8:265-71. IF:
1.289
Mannucci E, Monami M, Masotti G, Marchionni M. All-cause mortality in patients treated with
combinations of sulphonylureas and biguanides. Diabetes-Metab Res Rev 20: 44-47, 2004. IF 3.133
Mannucci E, SpilaAlegiani S, Monami M, Sarli E, Avogaro A, and the DAI Study Group. Indexes of
abdominal adiposity in patients with type 2 diabetes. J Endocrinol Invest27: 535-540, 2004. IF 1.525
Barchielli A., BuiattiE., Balzi D., Santoro G.M., Carrabba N., Fabiani P., Maci M., Margheri M.,
Mangani I., Monami M., Marchionni N. for the AMI-Florence Working Group. Age-Related Changes
in Treatment Strategies for Acute Myocardial Infarction: a Population-Based Study (the AMIFlorence Registry). JAGS52:1355-60. IF: 3.539
Ungar A, Pepe G, Monami M, Lambertucci L, Torrini M, Baldasseroni S, Tarantini F, Marchionni N,
Masotti G. Isolatedambulatoryhypertensionis common in outpatientsreferred to a hypertension
centre. J Human Hyper18:897-903. IF.2.244.
Monami M, Mannucci E, Breschi A, Marchionni N. Seizures as the only clinical manifestation of
reactive hypoglycaemia. A case report. J Endocrinol Invest28: 940-941, 2005. IF 1.525
Ungar A., Di Serio C., Lambertucci L., Monami M., Masotti G. Calcium Channel Blockers and
Nephroprotection. Aging Clinical and Experimental Research17:31-39. IF: 1.311
Balzi D., Barchielli A., Buiatti E., Franceschini C., Mangani I., Del Bianco L., Monami M., Valente S.,
Gensini G.F., Marchionni N. Age and comorbidity in acute myocardial infarction: a report from the
AMI-Florence Italian Registry, for the AMI-Florence Working Group. Am J GeriatrCardiol15:3541.IF.0.689
Balzi D., Barchielli A., Buratti E., Franceschini C, Lavecchia R, Monami M, Santoro GM, Carrabba N,
Margheri M, Olivotto I, Gensini GF, Marchionni N. Effect of comorbidity on
coronaryreperfusionstrategy and long-termmortalityafter acute myocardialinfarction. Am Heart J,
151:1101-1107. IF.3.649
Mannucci E, Monami M, Mannucci M, Chiasserini V, Nicoletti P, Gabbani L, Giglioli L, Masotti G,
Marchionni N. Incidence and prognosticsignificance of hypoglycaemia in older non-diabeticpatients
in hospital. AgingClinExp Res18: 446-451, 2006. IF 1.068
Monami M, Lambertucci L, Ungar A, Pieri M, Masotti G, Marchionni N, Mannucci E. Is the third
component of metabolic syndrome really predictive of outcome in type 2 diabetic patients? Diabetes
Care29: 2515-2517, 2006. IF 7.912
Mannucci E, Lambertucci L, Monami M, Fedeli A, Chiasserini V, Marchionni N, Masotti G, Ungar A.
Pulse pressure and mortality in hypertensivetype2diabeticpatients. A cohortstudy. Diabetes-Metab
Res Rev22: 172-175, 2006. IF 2.551
Monami M, Luzzi C, Lamanna C, Chiasserini V, Addante F, Masotti G, Marchionni N, Mannucci E.
Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues
and metformin. Diabetes-Metab Res Rev22: 482-487, 2006. IF 2.551
Monami M, Marchionni N, Masotti G, Mannucci E. Fasting and postprandial glycaemia and their
correlation with glycatedhaemoglobin in type 2 diabetes. J Endocrinol Invest29: 619-624, 2006. IF
1.469
Monami M, Lambertucci L, Lamanna C, Lotti E, Marsilii A, Masotti G, Marchionni N, Mannucci E. Is
the use of comorbidity indices useful in the prediction of all-cause mortality in type 2 diabetic
5/13
Curriculum Vitae30/01/2014
2.
3.
4.
5.
6.
7.
2008
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
2009
1.
Matteo Monami
patients? Comparison between Charlson index and disease count. Aging ClinExp Res19: 492-496,
2007. IF 1.460
Monami M, Balzi D, Lamanna C, Barchielli A, Masotti G, Buiatti E, Marchionni N, Mannucci E. Are
sulphonylureasall the same? A cohort study on cardiovascular and cancer-related mortality.
Diabetes-Metab Res Rev23: 479-484, 2007. IF 3.087
Monami M, Balzi D, Lamanna C, Melani C, Cocca C, Lotti E, Fedeli A, Masotti G, Marchionni N,
Mannucci E.Prognosticvalue of serumliverenzymes in type 2 diabeticpatients. Diabetes-Metab Res
Rev23: 625-630, 2007. IF 3.087
Monami M, Marchionni N, Masotti G, Mannucci E. IDF and ATP-III definitions of metabolic syndrome
in the prediction of all-cause mortality in type 2 diabetic patients. Diabetes ObesMetab9: 350-353,
2007. IF 3.441
Monami M, Marchionni N, Masotti G, Mannucci E. Prognostic value of IDF and ATP-III definitions of
metabolic syndrome in type 2 diabetic patients: what makes the difference? J Endocrinol Invest30:
626-630, 2007. IF 2.021
Mannucci E, Monami M, Bardini G, Ognibene A, Rotella CM. National Cholesterol Education
Program (NCEP) and International Diabetes Federation (IDF) diagnostic criteria for metabolic
syndrome in an Italian cohort. Results from the FIBAR Study. J Endocrinol Invest30: 925-930, 2007.
IF 2.021
Mannucci E, Monami M, Rotella CM. How many components for the metabolic syndrome? Results
of exploratory factor analysis in the FIBAR study. NutrMetabCardiovasc Dis17: 119-126, 2007. IF
3.174
Balzi D, Barchielli A, Santoro GM, Carrabba N, Buiatti E, Giglioli C, Valente S, Baldereschi G, Del
Bianco L, Monami M, Gensini GF, Marchionni N. Management of acute myocardial infarction in the
real world: a summary report from the Ami-florenceitalian registry. Internal and Emergency
Medicine, 2008, Jun;3(2):109-115. (I.F. 0.000);
Monami M, Cresci B, Colombini A, Pala L, Balzi D, Gori F, Chiasserini V, Marchionni N, Rotella CM,
Mannucci E. Bone fractures and hypoglycaemic treatment in type 2 diabetic patients: a case-control
study. Diabetes Care31: 199-2003, 2008. IF 7.349
Monami M, Lamanna C, Marchionni N, Mannucci E.Rosiglitazone and risk of cancer. A metaanalysis of randomized clinical trials. Diabetes Care31: 1455-1460, 2008. IF 7.349
Mannucci E, Monami M, Cresci B, Pala L, Bardini G, Petracca MG, Decembrini I, Pasqua A, Buiatti
E, Rotella CM. National Cholesterol Education Program (NCEP) and International Diabetes
Federation (IDF) definitions of metabolic syndrome in the prediction of diabetes. Results from the
FIBAR Study. Diabetes ObesMetab9: 430-435, 2008. IF 4.259
Mannucci E, Monami M, Lamanna C, Gensini GF, Marchionni N. Pioglitazone and
cardiovascularrisk. A comprehensive meta-analysis of randomized clinical trials. Diabetes
ObesMetab9: 1231-1238, 2008. IF 4.259
Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E.Skinautofluorescence in
type 2 diabetes: beyondbloodglucose. Diabetes Res ClinPract79: 57-60, 2008. IF 2.754
Monami M, Lamanna C, Marchionni N, Mannucci E. Comparison of different drugs as add-on
treatments to metformin in type 2 diabetes: a meta-analysis. Diabetes Res ClinPract79: 196-203,
2008. IF 1.888
Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues versus NPH insulin in type 2
diabetes. A meta-analysis. Diabetes Res ClinPract81: 184-189, 2008. IF 1.888
Monami M, Marchionni N, Mannucci E. Winners and losers at the rosiglitazone gamble. A metaanalytical approach at the definition of the cardiovascular risk profile of rosiglitazone. Diabetes Res
ClinPract82: 48-56, 2008. IF 1.888
Monami M, Lamanna C, Pala L, Bardini G, Cresci B, Francesconi P, Balzi D, Marchionni N, Rotella
CM, Mannucci E. Treatment with insulin secretagogues and cancer-related mortality in type 2
diabetic patients. A retrospective cohort study. ExpClinEndocrinol Diabetes116: 184-189, 2008. IF
1.896
Monami M, Marchionni N, Masotti G, Mannucci E. Effect of combined secretagogue-biguanide
treatment on mortality in type 2 diabetic patients with and without ischemic heart disease. Int J
Cardiol126: 247-251, 2008. IF 3.121
Monami M, Longo R, Desideri CM, Masotti G, Marchionni N, Mannucci E. The diabetic person
beyond a foot ulcer: prognostic value of depressive symptoms. J Am Pod Med Ass98: 130-136,
2008. IF 0.586
Monami M, Lamanna C, Balzi D, Bartalucci F, Melani C, Masotti G, Marchionni N, Mannucci E.
Metabolic syndrome and cardiovascular mortality in older type 2 diabetic patients: a longitudinal
study. J Gerontol A Biol Med Sci23: 625-630, 2007. IF 4.003
Monami M, Bardini G, Lamanna C, Pala L, Cresci B, Francesconi P, Buiatti E, Rotella CM,
Mannucci E. Liver enzymes and risk of diabetes and cardiovascular disease: results of the FirenzeBagno a Ripoli (FIBAR) study. Metabolism57: 387-392, 2008. IF 2.920
Monami M, Pala L, Bardini G, Francesconi P, Cresci B, Marchionni N, Rotella CM, Mannucci
E.Glomerularhyperfiltration and metabolicsyndrome: results from the Firenze-Bagno a Ripoli
(FIBAR) Study. Acta Diabetol46:191-196, 2009. IF 1.549
6/13
Curriculum Vitae30/01/2014
Matteo Monami
2.
Monami M, Lamanna C, Balzi D, Marchionni N, Mannucci E. Sulphonylureas and cancer: a casecontrol study. ActaDiabetol46: 279-284, 2009. IF 1.549
3. Ricca V, Castellini G, Mannucci E, Monami M, Ravaldi C, GoriniAmedei S, Sauro CL, Rotella CM,
Faravelli C. Amphetaminederivatives and obesity. Appetite52: 405-409, 2009. IF 2.582
4. Monami M, Vivarelli M, Desideri C, Colombi C, Marchionni N, Mannucci E.Pulse pressure and
prediction of incidentfootulcers in type 2 diabetes. Diabetes Care32: 897-899, 2009. IF 6.718
5. Mannucci E, Monami M, Marchionni N. Short-acting insulin analogues versus regular human insulin
in type 2 diabetes: a meta-analysis. Diabetes ObesMetab11: 53-59, 2009. IF 4.126
6. Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues versus NPH human insulin in
type 1 diabetes. A meta-analysis. Diabetes ObesMetab11: 372-378, 2009. IF 4.126
7. Monami M, Marchionni N, Mannucci E. Glucagon-like peptide-1 receptor agonists in type 2 diabetes:
a meta-analysis of randomized clinical trials. Eur J Endocrinol160: 909-917, 2009. IF 3.539
8. Monami M, Lamanna C, Marchionni N, Mannucci E. Continuous subcutaneous insulin injection
versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
ExpClinEndocrinolDiab117: 220-222, 2009. IF 1.685
9. UngarA, Pepe G, Lambertucci L, Fedeli A, Monami M, Mannucci E, Gabbani L, Marchionni N,
Masotti M, Marchionni N, Di Bari M. Low diastolic ambulatory blood pressure is associated with
greater all-cause mortality in older patients with hypertension. J Am GeriatrSoc57: 291-296, 2009. IF
3.656
10. Corona G, Mannucci E, Jannini EA, Lotti F, Ricca V, Monami M, Boddi V, Bandini E, Balercia G,
Forti G, Maggi M. Hypoprolactinemia: a new clinicalsyndrome in patients with sexualdysfunction. J
SexualMed6: 1457-1466, 2009. IF 4.884
11. Corona G, Mannucci E, Lotti F, Boddi V, Jannini EA, Fisher AD, Monami M, Sforza A, Forti G, Maggi
M. Impairment of Couple Relationship in Male Patients with Sexual Dysfunction is Associated with
Overt Hypogonadism. J Sexual Med6: 2591-2600, 2009. IF 4.884
12. Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N. Prevention of cardiovascular disease
through glycaemic control in type 2 diabetes. A meta-analysis of randomized clinical trials.
NutrMetabCardiovasc Dis 19: 604-6012, 2009. IF 3.517
7/13
Curriculum Vitae30/01/2014
Matteo Monami
2010
1.
Pala L, Monami M, Lamanna C, Cresci B, Colombi C, Bardini G, Sposato J, Marchionni N, Rotella
CM, Mannucci E. Failure to metformin and insulin secretagoguemonotherapy: an observational
cohort study. ActaDiabetol47(suppl. 1): 7-11, 2010. IF 3.175
2. Monami M, Lamanna C, Marchionni N, Mannucci E. Continuous subcutaneous insulin infusion
versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. ActaDiabetol47(suppl. 1):
77-81, 2010. IF 3.175
3. Mannucci E, Monami M, Balzi D, Cresci B, Pala L, Melani C, Lamanna C, Bracali I, Bigiarini M,
Barchielli A, Marchionni N, Rotella CM. Doses of insulin and its analogues and cancer occurrence in
insulin-treated type 2 diabetic patients. Diabetes Care33: 1997-2003, 2010. IF 7.141
4. Mannucci E, Monami M, Di Bari M, Lamanna C, Gensini GF, Marchionni N. Cardiacsafetyprofile of
rosiglitazone. A comprehensive meta-analysis of randomized clinical trials. Int J Cardiol143: 135140, 2010. IF 6.802
5. Innocenti F, Agresti C, Baroncini C, Caldi F, Mannucci E, Monami M, Pini R. Prognosticvalue of
domutamine stress echocardiography in diabeticpatients. Int J Cardiovasc Imaging 26: 499-507,
2010. IF 2.539
6. Mannucci E, Pala L, Monami M, Da Vico L, Bardini G, Dicembrini I, Ciani S, Lamanna C, Marchionni
N, Rotella CM. Glucagon-like Peptide-1 response to meals and post-prandial hyperglycemia in type
2 diabetic patients. J Endocrinol Invest33: 147-150, 2010. IF 1.476
7. Corona G, Monami M, Boddi V, Cameron-Smith M, Fisher AD, De Vita G, Melani C, Balzi D, Sforza
A, Forti G, Mannucci E, Maggi M. Low testosterone is associated with an increased risk of MACE
lethality in subjects with erectile dysfunction. J Sexual Med7: 1557-1564, 2010. IF 3.957
8. Corona G, Monami M, Boddi V, Cameron-Smith M, Lotti F, de Vita G, Melani C, Balzi D, Sforza A,
Forti G, Mannucci E, Maggi M. Male sexuality and cardiovascular risk: a color study in patients with
erectile dysfunction. J Sexual Med7: 1918-1927, 2010. IF 3.957
9. Corona G, Monami M, Boddi V, Balzi D, Melani C, Federico N, Sforza A, Rotella CM, Forti G,
Mannucci E, Maggi M. Is obesity a further cardiovascular risk factor in patients with erectile
dysfunction? J Sexual Med7: 2538-2546, 2010. IF 3.957
10. Boddi V, Corona G, Monami M, Fisher AD, Bandini E, Melani C, Balzi D, Sforza A, Patussi V, Forti
G,Mannucci E, Maggi M. PriapusisHappier with Venus than with Bacchus. J Sexual Med7: 28312841, 2010. IF 3.957
11. Bandini E, Fisher AD, Corona G, Ricca V, Monami M, Boddi V, Balzi D, Melani C, Forti G, Mannucci
E, Maggi M. Severe Depressive Symptoms and Cardiovascular Risk in Subjects with Erectile
Dysfunction. J Sexual Med7: 3477-3486, 2010. IF 3.957
12. Monami M, Iacomelli I, Marchionni N, Mannucci E. Dipeptidyl-Peptidase 4 inhibibitors in type 2
diabetes: a meta-analisys of randomized clinical trials. NutrMetabCardiovasc Dis20: 224-235, 2010.
IF 3.438
2011
1.
Monami M, Dicembrini I, Martelli D, Mannucci E.Safety of dipeptydil-peptidase 4 inhbitors. A metaanalysis of randomized clinical trials. Curr Med Res Opin27 Suppl 3: 57-64, 2011. IF 2.380
2. Monami M, Colombi C, Balzi D, Dicembrini I, Giannini S, Melani C, Vitale V, Romano D, Barchielli A,
Marchionni N, Rotella CM, Mannucci E.Metformin and canceroccurrence in insulin-treatedtype 2
diabeticpatients. Diabetes Care34: 129-131, 2011. IF 8.087
3. Monami M, Dicembrini I, Antenore A, Mannucci E. Dipeptidyl Peptidase 4 inhibitors and bone
fractures. A meta-analysis of randomized clinical trials. Diabetes Care34: 2474-2476, 2011. IF 8.087
4. Monami M, Cremasco F, Lamanna C, Marchionni N, Mannucci E. Predictors of response to
dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials. Diabetes-Metab Res
Rev27: 362-372, 2011. IF 3.373
5. Lamanna C, Monami M, Marchionni N, Mannucci E. Effect of metformin on cardiovascular events
and mortality: a meta-analysis of randomized clinical trials. Diabetes ObesMetab13: 221-228, 2011.
IF 3.379
6. Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, Forti G, Mannucci E, Maggi M.
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J
Endocrinol165: 687-701, 2011. IF 3.423
7. Monami M, Cremasco F, Lamanna C, Colombi C, Desideri CM, Iacomelli I, Marchionni N, Mannucci
E. Glucagon-like peptide-1 receptor agonists and cardiovascular events: a meta-analysis of
randomized clinical trials. Exp Diabetes Res2011: 215764, 2011. IF 1.200
8. Corona G, Rastrelli G, Boddi V, Monami M, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi
M. Prolactin levels independently predict major cardiovascular events in patients with erectile
dysfunction. Int J Androl34: 217-224, 2011. IF 3.591
9. Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, Forti G, Mannucci E, Maggi M.
Type2diabetesmellitus and testosterone: a meta-analysisstudy. Int J Androl34: 528-540, 2011. IF
3.591
10. Commisso L, Monami M, Mannucci E.Periodontaldisease and oralhygienehabits in a type 2
diabeticpopulation. Int J DentHyg9: 68-73, 2011. IF 0.871
11. Bandini E, Fisher AD, Ricca V, Ristori J, Meriggiola M, Jannini EA, Manieri C, Corona G, Monami M,
Fanni E, Galleni A, Forti G,Mannucci E, Maggi M. Childhoodmaltreatment in subjects with male-tofemale gender identitydisorder. Int J Impot Res23: 276-285, 2011. IF 1.712
12. Monami M, Vivarelli M, Desideri CM, Ippolito G, Marchionni N, Mannucci E. Autologous skin
8/13
Curriculum Vitae30/01/2014
13.
14.
15.
16.
17.
2012
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
2013
1.
2.
3.
4.
Matteo Monami
fibroblast and keratinocyte grafts in the treatment of chronic foot ulcers in aging type 2 diabetic
patients. J Am Podiatr Med Assoc101: 55-58, 2011. IF 0.567
Corona G, Monami M, Boddi V, Rastrelli G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi
M. Pulse Pressure Independently Predicts Major Cardiovascular Events in Younger But Not in Older
Subjects with Erectile Dysfunction. J Sexual Med8: 247-254, 2011. IF 3.552
Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E,
Maggi M. Testosterone and metabolicsyndrome: a meta-analysisstudy. J SexualMed8: 272-283,
2011. IF 3.552
Corona G, Monami M, Rastrelli G, Melani C, Balzi D, Sforza A, Forti G,Mannucci E, Maggi M.
IsMetabolicSyndrome a UselessCategory in Subjects with High CardiovascularRisk? Results from a
Cohort Study in Men with Erectile Dysfunction. J Sexual Med8: 504-511, 2011. IF 3.552
Corona G, Rastrelli G, Monami M, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M. Body
mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with
erectile dysfunction. J Sexual Med8: 2098-2105, 2011. IF 3.957
Rastrelli G, Corona G, Monami M, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M. Poor
Response to Alprostadil ICI Test is Associated with Arteriogenic Erectile Dysfunction and Higher
Risk of Major Adverse Cardiovascular Events. J Sexual Med8: 3433-3345, 2011. IF 3.552
Mannucci E, Monami M, Lamanna C, AldasteinssonJE.Post-prandial glucose and diabetic
complications: systematic review of observational studies. ActaDiabetol49: 307-314, 2012. IF 4.631
Rotella F, Cresci B, Monami M, Aletti V, Andreoli V, Ambrosio ML, Ricca V, Dicembrini I, Mannucci
E. Are psychopathological features relevant predictors of glucose control in patients with type 2
diabetes? A prospective study. ActaDiabetol49 Suppl 1: S179-184, 2012. IF 4.631
Monami M, Lamanna C, Desideri CM, Mannucci E. DPP4 inhibitors and lipids: systematic review
and meta-analysis. AdvTher29: 14-25, 2012. IF 2.125
Monami M, Vitale V, Ambrosio ML, Bartoli N, Toffanello G, Ragghianti B, Monami F, Marchionni N,
Mannucci E. Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and
sulfonylureas: meta-analysis of placebo-controlled trials. AdvTher29: 736-746, 2012. IF 2.125
Baldasseroni S, Antenore A, Di Serio C, Orso F, Lonetto G, Bartoli N, Foschini A, Marella A, Pratesi
A, Scarantino S, Fumagalli S, Monami M, Mannucci E, Marchionni N, Tarantini F. Adiponectin,
diabetes and ischemicheartfailure: a challengingrelationship. CardiovascDiabetol11:151, 2012. IF
4.209
Monami M, Dicembrini I, Marchionni N, Rotella CM, Mannucci E. Effects of Glucagon-like peptide-1
receptor agonists on body weight: a meta-analysis. Exp Diabetes Res2012: 672658, 2012. IF 1.893
Fisher AD, Bandini E, Corona G, Monami M, Cameron Smith M, Melani C, Balzi D, Forti G,
Mannucci E, Maggi M. Stable extramarital affairs are breaking the heart. Int J Androl35: 11-17,
2012. IF 3.565
Innocenti F, Baroncini C, Agresti C, Mannucci E, Monami M, Pini R. Left ventricular cavity
obliteration during dobutamine stress echocardiography in diabetic patients. Int J Cardiovasc
Imaging28: 1023-1033, 2012. IF 2.684
Giannini S, Bardini G, Dicembrini I, Monami M, Rotella CM, Mannucci E. Lipid levels in obese and
nonobese subjects as predictors of fasting and postload glucose metabolism. J ClinLipidol6: 132138, 2012. IF 2.741
Monami M, UngarA, Lamanna C, Bardini G, Pala L, Dicembrini I, Marchi C, Vivarelli M, Zannoni S,
Bartoli N, Marchionni N, Rotella CM, Mannucci E. Effects of anti-hypertensive treatment on the
incidence of diabetes: a case-control study. J EndocrinolInvest35: 135-138, 2012. IF 1.654
Pala L, Monami M, Ciani S, Dicembrini I, Pasqua A, Pezzatini A, Francesconi P, Cresci B, Mannucci
E, Rotella CM. Adipokines as possible new predictors of cardiovascular disease: a case-control
study. J NutrMetab2012: 253428, 2012.
Fisher AD, Bandini E, Rastrelli G, Corona G, Monami M, Mannucci E, Maggi M. Sexual and
Cardiovascular Correlates of Male Unfaithfulness. J Sex Med9: 1508-1518, 2012. IF 3.513
Corona G, Rastrelli G, Balercia G, Lotti F, Sforza A, Monami M, Forti G, Mannucci E, Maggi M.
Hormonal Association and Sexual Dysfunction in Patients with Impaired Fasting Glucose: A CrossSectional and Longitudinal Study. J Sex Med9: 1669-1680, 2012. IF 3.513
Fisher AD, Rastrelli G, Bandini E, Corona G, Balzi D, Melani C, Monami M, Matta V, Mannucci E,
Maggi M. Metabolic and cardiovascular outcomes of fatherhood: results from a cohort of study in
subjects with sexual dysfunction. J Sex Med9: 2785-2794, 2012. IF 3.513
Da Vico L, Monami M, Biffi B, Lamanna C, Martelli C, Marchionni N, Mannucci E. Targeting
educational therapy for type 2 diabetes: identification of predictors of therapeutic success.
ActaDiabetol50: 309-317, 2013. IF 4.631
Monami M, Mannucci E. Efficacy and safety of degludec insulin: a meta-analysis of randomised
trials. Curr Med Res Opin29: 339-342, 2013. IF 2.263
Monami M, Filippi L, Ungar A, Sgrilli F, Antenore A, Dicembrini I, Bagnoli P, Marchionni N, Rotella
CM, Mannucci E. Further data on beta-blockers and cancer risk: observational study and metaanalysis of randomized clinical trials. Curr Med Res Opin29: 369-378, 2013. IF 2.263
Monami M, Ahrén B, Dicembrini I, Mannucci E. Dipeptidyl peptidase-4 inhibitors and cardiovascular
risk: a meta-analysis of randomized clinical trials. Diabetes ObesMetab15: 112-120, 2013. IF 5.181
9/13
Curriculum Vitae30/01/2014
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
2014
Matteo Monami
Corona G, Rastrelli G, Monami M, Saad F, Luconi M, Lucchese M, Facchiano E, Sforza A, Forti G,
Mannucci E, Maggi M. Body weight loss reverts obesity-associated
hypogonadotropichypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 168:
829-843. 2013. IF 3.136
Baldasseroni S, Mannucci E, Di Serio C, Orso F, Bartoli N, Mossello E, Foschini A, Monami M,
Valoti P, Fumagalli S, Colombi C, Pellerito S, Gensini G, Marchionni N, Tarantini F. Resistin level in
coronary artery disease and heart failure: the central role of kidney function. J Cardiovasc Med14:
150-157, 2013. IF 2.657
Fisher AD, Bandini E, Casale H, Ferruccio N, Meriggiola MC, Gualerzi A, Manieri C, Jannini E,
Mannucci E, Monami M, Stomaci N, Delle Rose A, Susini T, Ricca V, Maggi M. Sociodemographic
and clinicalfeatures of gender identitydisorder: an Italianmulticentricevaluation. J Sex Med 10: 408419, 2013. IF 3.513
Corona G, Rastrelli G, Ricca V, Jannini EA, Vignozzi L, Monami M, Sforza A, Forti G, Mannucci E,
Maggi M. Risk factors associated with primary and secondary reduced libido in male patients with
sexual dysfunction. J Sex Med10: 1074-1089, 2013. IF 3.513
Corona G, Rastrelli G, Silverii A, Monami M, Sforza A, Forti G, Mannucci E, Maggi M. The
identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients
with erectile dysfunction. J Sex Med10:1114-1123, 2013. IF 3.513
Monami M, Vitale V, Lamanna C, Bartoli N, Martelli D, Zannoni S, Antenore A, Toffanello G,
Marchionni N, Mannucci E. HbA1c levels and all-cause mortality in type 2 diabetic patients:
epidemiological evidence of the need for personalised therapeutic targets. NutrMetabCardiovasc Dis
23: 300-306, 2013. IF 3.978
Monami M, Adalsteinsson JE, Desideri CM, Ragghianti B, Dicembrini I, Mannucci E. Fasting and
post-prandial glucose and diabetic complication. A meta-analysis. NutrMetabCardiovasc Dis23: 591598, 2013. IF 3.978
Corona G, Rastrelli G, Monami M, Maseroli E, Jannini EA, Balercia G, Sforza A, Forti G, Mannucci
E, Maggi M. Frequency of sexual activity and cardiovascular risk in subjects with erectile
dysfunction: cross-sectional and longitudinal analyses. Andrology. 1:864-871. IF 3.513
Rastrelli G, Corona G, Vignozzi L, Maseroli E, Silverii A, Monami M, Mannucci E, Forti G, Maggi M.
Serum PSA as a Predictorof Testosterone Deficiency. J Sex Med10: 2518-2528.. IF 3.513
Monami M, Genovese S, Mannucci E. Cardiovascular safety of sulfonylureas: a meta-analysis of
randomized clinical trials. Diabetes ObesMetab15: 938-953. IF 5.181
Crawford F, Anandan C, Chappell FM, Murray GD, Price JF, Sheikh A, Simpson CR, Maxwell M,
Stansby GP, Young MJ, Abbott CA, Boulton AJ, Boyko EJ, Kastenbauer T, Leese GP, Monami M,
Monteiro-Soares M, Rith-Najarian SJ, Veves A, Coates N, Jeffcoate WJ, Leech N, Fahey T, Tierney
J.Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of
foot ulceration in people with diabetes: the international research collaboration for the prediction of
diabetic foot ulcerations (PODUS). BMC Med Res Methodol13:22.
1.
Monami M, Dicembrini I, Mannucci E. Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a
meta-analysis of randomized clinical trials. Diabetes ObesMetab 16:48-56. IF 5.181
2. Monami M, Dicembrini I, Nardini C, Fiordelli I, Mannucci E. Effects of glucagon-like peptide-1
receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes
ObesMetab16: 38-47. IF 5.181
3. Monami M, Dicembrini I, Mannucci E.Thiazolidinediones and cancer: results of a meta-analysis of
randomized clinical trials. ActaDiabetol;51(1):91-101. IF 4.631.
4. Mannucci E, Genovese S, Monami M, Navalesi G, Dotta F, Anichini R, Romagnoli F, Gensini G.
Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a
randomized, double-blind, placebo-controlled study-the D.A.N.T.E (Diabetic ulcer Antimicrobial New
Topical treatment Evaluation) study. Acta Diabetol. 51(3):435-40. IF. 4.631.
5. Monami M, Nardini C, Mannucci E. Efficacy and safety of sodium glucose co-transport-2 inhibitors
in type 2 diabetes: a meta-analysis of randomized clinical trials. Diabetes Obes Metab. 16(5):45766. IF 5.181.
6. Ambrosio ML, Monami M, Sati L, Marchionni N, Di Bari M, Mannucci E.GLP-1 receptoragonistinducedpolyarthritis: a case report. Acta Diabetol. 51(4):673-4.
7. Mannucci E, Monami M, Dicembrini I, Piselli A, Porta M. Achieving HbA1c targets in clinical trials
and in the real world: a systematic review and meta-analysis. J Endocrinol Invest. 37(5):477-95.
8. Innocenti F, Bartalucci F, Boni V, Vicidomini S, Mannucci E, Monami M, Pini R. Coronary artery
disease screening in type II diabetic patients: prognostic value of rest and stress echocardiography.
Diabetes Metab Syndr. 8(1):18-23.
9. Monami M, Dicembrini I, Kundisova L, Zannoni S, Nreu B, Mannucci E. A meta-analysis of the
hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2
diabetes. Diabetes Obes Metab.16(9):833-40. 6.
10. Monami M, Dicembrini I, Nardini C, Fiordelli I, Mannucci E. Glucagon-like peptide-1 receptor
agonists and pancreatitis: a meta-analysis of randomized clinical trials. Diabetes Res Clin Pract.
103(2):269-75
11. Monami M, Dicembrini I, Mannucci E. Dipeptidyl peptidase-4 inhibitors and heart failure: a metaanalysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 24(7):689-97.
10/13
Curriculum Vitae30/01/2014
1.
In
press
Matteo Monami
Artuso R, Provenzano A, Mazzinghi B, Giunti L, Palazzo V, Andreucci E, Blasetti A, Chiuri RM,
Gianiorio FE, Mandich P, Monami M, Mannucci E, Giglio S. Therapeutic implications of novel
mutations of the RFX6 gene associated with early-onset diabetes. Pharmacogenomics J. 2014 Jul
22. doi: 10.1038/tpj.2014.37. [Epub ahead of print]
*Impact Factor calcolato per ciascun anno, mentre viene calcolato su base 2012 per l’anno 2013 e
per gli articoli in press.
Revisioni ed editoriali
Reviews and Editorials
2006
1.
2.
2009
1.
2.
2011
1.
2.
2012
1.
2.
2013
1.
Rotella CM, Monami M, Mannucci E. Metformin beyond diabetes: new life for an old drug. Curr
Diabetes Rev2: 307-315, 2006.
Monami M. Diagnosis of metabolic syndrome in diabetes patients is of little value. Diabetic
microvascular complications today 2006, 6:25 (IF: 0.000);
Mannucci E, Monami M. Is the evidence from clinical trials for cardiovascular risk or harm for
glitazones convincing? Curr Diabetes Rep9: 324-327, 2009. IF 2.496
Mannucci E, Monami M. Liraglutide and its effects on HbA1c and weight control: a two-year
experience. ObesMetab5: 152-155, 2009. IF 0.311
Mossello E, Ballini E, Boncinelli M, Monami M, Lonetto G, Mello AM, Tarantini F, Baldasseroni S,
Mannucci E, Marchionni N. Glucagon-like Peptide-1, diabetes, and cognitive decline: possible
pathophysiological links and therapeutic opportunities. Exp Diabetes Res2011: 281674, 2011. IF
1.200
Monami M. Glucagon-like peptide-1 and diabetes.Exp Diabetes Res. :901954. IF 1.200
Paolisso G, Monami M, Marfella R, Rizzo MR, Mannucci E. Dipeptidyl peptidase-4 inhibitors in the
elderly: more benefits or risks? AdvTher29: 218-233, 2012. IF 2.125
Monami M, Di Pasquale G, Rowzee A, Rotella CM, Mannucci E. Glucagon-like peptide-1 and diabetes
2012. Exp Diabetes Res2012: 768760, 2012. IF 1.893
Monami M.Metformin may not reduce cardiovascular risk or all-cause mortality.EvidBasedMed18:e13.
Lettere (osservazioni originali)
Letters (originalobsevations)
2002
1.
2.
2007
1.
2.
3.
4.
Monami M, Mannucci E, Masotti G. Finger sepsis in two poorly controlled diabetic patients with reuse
of lancets. Diabetes Care25: 1103, 2002. IF 5.477
Monami M, Mannucci E, Masotti G. Use of an oxidised regenerated cellulose and collagen composite
for healing of chronic diabetic foot ulcers. Diabetes Care25: 1892-1893, 2002. IF 5.477
Mannucci E, Monami M, Pala L, Cocca C, Cresci B, Bardini G, Masotti G, Marchionni N, Rotella CM.
Management of type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A
consensus statement from the American Diabetes Association and the European Association for the
Study of Diabetes. Response to Nathan et al. Diabetes Care30: 193-194, 2007. IF 7.851
Mannucci E, Monami M, Bardini G, Sposato I, Ungar A, Pepe G, Masotti G, Marchionni N, Rotella CM.
Metabolicsyndrome and pulse pressure. DiabetesObesMetab9: 600-602, 2007. IF 3.441
Mannucci E, Monami M, Masotti G, Marchionni N. Is basal insulin always the first choice for the
initiation in insulin therapy in type 2 diabetic patients? ExpClinEndocrinol Diabetes115: 339-340, 2007.
IF 1.745
Mannucci E, Monami M, Marchionni N. Rosiglitazone and cardiovascularrisk. N Engl J Med357: 938,
11/13
Curriculum Vitae30/01/2014
Matteo Monami
2007. IF 52.589
2011
1.
Monami M, Bigiarini M, Rotella CM, Mannucci E.Inaccuracy in meta-analysis on rosiglitazone and
myocardialinfarction. NutrMetabCardiovascDis21: e7-e8, 2011. IF 3.731
2013
1.
Mannucci E, Monami M, Dicembrini I, Rotella C. The impossible return to the Garden of Eden: The
ORIGIN trial and the original sin of early insulin treatment of type 2 diabetes. NutrMetabCardiovasc
Dis23: e35-e36, 2013. IF 3.731
Partecipazione a gruppi di studio - Articoli originali *
2003
1.
Buiatti E, Barchielli A, Marchionni N, Balzi D, Carrabba N, Valente S, Olivotto I, Landini C, Filice M,
Torri M, Regoli G, M Santoro G and the AMI-Florence workinggroup. The Determinants of treatment
strategies and survival in acute myocardial infarction: a population-based study in the Florence district,
Italy. Results of the acute myocardial infarction Florence registry (AMI-Florence), Eur Heart J. 2003,
24(13):1195-1203. (IF: 7.924)
2004
1.
Carrabba N, Santoro GM, Balzi D, Barchielli A, Marchionni N, Fagiani P, Landini C, Scarti L, Santoro
G, Valente S, verdini V, Buratti E and the AMI-Florence Working Group. In-hospital Management and
Outcome in Women with Acute Myocardial Infarction. (Data from the AMI-Florence Registry). Gender
differences in treatment and outcome. Am J Card. 2004, 94(9):1118-1123. (IF: 3.603)
Barchielli A, Balzi D, Marchionni N, Carrabba N, Margheri M, Santoro GM, Olivotto I, Buiatti E and the
AMI-Florence working group. Early discharge after acute myocardial infarction in the current clinical
practice. Community data from the AMI-Florence Registry, Italy. Int J Card 2006, 114(1):57-63. (IF:
2.878)
1. Santoro G, Carrabba N, Barchielli A, Balzi D, Marchionni N, Filice M, Valente S, Granelli M, Berni I,
2013
Buiatti E. Use and efficacy of abciximab in an unselected population with acute myocardial infarction
treated with primary angioplasty: Data from AMI-Florence registry. Atherosclerosis 2007, 195(1):116121. (IF: 3.811)
*Non rientrano nel calcolo totale dell’Impact Factor.
2006
1.
RIVISTE NAZIONALI
NATIONAL JOURNALS
Articoli originali
OriginalArticles
2000
1.
2.
2002
1.
2.
Girardi C., Pepe G., Monami M., Balestra M., Fallani G.M., Lepori T., Pientini S., Ungar A.
Modificazioni età correlate delle principali variabili tipiche del monitoraggio pressorio nelle 24 ore,
GiornGeront 2000; 48, 12:945-947.
Marchionni N., Fumagalli S., Boncinelli L., Valoti P., Baldereschi G., M. Monami, Masotti G. La
intensività in unità geriatrica per acuti, GiornGeront 2000; 48, 10:684-691.
Marchionni N., Monami M., Lavecchia R., Baldasseroni S. Stato psico-affettivo e condizioni di salute
fisica nell’anziano, GiornGeront 2002, 50, 2: 67-80.
Marchionni N., Cherubini A., Bernabei R., Sgadari A., Trojano L., Monami M., Lavecchia R., Lattanzio
F. La ricerca nell’ambulatorio geriatrico: lo studio DAFNE, GiornGeront 2002; 50, S5:346-354
G. Masotti, E. Mannucci, M. Monami, L. Lambertucci, A. Ungar. Ipertensione e sindrome metabolica
nell’anziano GiornGeront 2004; 51, 562-565.
2004
1.
2005
1.
Mannucci E., Monami M., Masotti G., Marchionni N. Terapia ipoglicemizzante e rischio
cardiovascolare nel paziente diabetico anziano. Giornale dell’Aterosclerosi 2005; Vol XXIX, 1:17-32.
2007
1.
Monami M., Marchionni N., Disturbi psico-affettivi e malattie cardiovascolari, Giornale Italiano
Cardiologia 2007; 8(6):335-48.
2009
1.
Monami M. Iperglicemia postprandiale e impatto sul rischio cardiovascolare. Italian Journal of
Medicine 2009; 3:5-7
LIBRI
BOOKS
In qualità di autore
12/13
Curriculum Vitae30/01/2014
Matteo Monami
As Author
2006
1.
Mannucci E, Monami M, Lamanna C. Gestione farmacologica del diabete di tipo 2: dalle evidenze alla
pratica clinica.Pacini, Pisa.
13/13